XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2019   48,526      
Beginning balance at Dec. 31, 2019 $ 160,206 $ 121 $ 582,504 $ (7,871) $ (414,548)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 10,937     3,808 7,129
Issuance of common stock upon exercise of stock options (in shares)   322      
Issuance of common stock upon exercise of stock options 1,387 $ 1 1,386    
Issuance of common stock under employee stock purchase plan (in shares)   204      
Issuance of common stock under employee stock purchase plan 1,332 $ 1 1,331    
Issuance of common stock for vested restricted stock units (in shares)   1,288      
Issuance of common stock for vested restricted stock units 0 $ 3 (3)    
Tax withholding related to vesting of restricted stock units (in shares)   (202)      
Tax withholding related to vesting of restricted stock units (1,722) $ (1) (1,721)    
Stock-based compensation costs 9,378   9,378    
Ending Balance (in shares) at Sep. 30, 2020   50,138      
Ending balance at Sep. 30, 2020 181,518 $ 125 592,875 (4,063) (407,419)
Beginning balance (in shares) at Jun. 30, 2020   49,547      
Beginning balance at Jun. 30, 2020 179,028 $ 124 590,800 (9,380) (402,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) 414     5,317 (4,903)
Issuance of common stock upon exercise of stock options (in shares)   7      
Issuance of common stock upon exercise of stock options 40   40    
Issuance of common stock for vested restricted stock units (in shares)   690      
Issuance of common stock for vested restricted stock units 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock units (in shares)   (106)      
Tax withholding related to vesting of restricted stock units (936) $ (1) (935)    
Stock-based compensation costs 2,972   2,972    
Ending Balance (in shares) at Sep. 30, 2020   50,138      
Ending balance at Sep. 30, 2020 181,518 $ 125 592,875 (4,063) (407,419)
Beginning balance (in shares) at Dec. 31, 2020   50,457      
Beginning balance at Dec. 31, 2020 180,407 $ 126 597,460 1,735 (418,914)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (30,539)     (555) (29,984)
Issuance of common stock upon exercise of stock options (in shares)   529      
Issuance of common stock upon exercise of stock options 2,967 $ 1 2,966    
Issuance of common stock under employee stock purchase plan (in shares)   235      
Issuance of common stock under employee stock purchase plan 1,549 $ 1 1,548    
Issuance of common stock for vested restricted stock units (in shares)   1,883      
Issuance of common stock for vested restricted stock units 0 $ 5 (5)    
Tax withholding related to vesting of restricted stock units (in shares)   (445)      
Tax withholding related to vesting of restricted stock units (4,952) $ (1) (4,951)    
Stock-based compensation costs 7,709   7,709    
Ending Balance (in shares) at Sep. 30, 2021   52,659      
Ending balance at Sep. 30, 2021 157,141 $ 132 604,727 1,180 (448,898)
Beginning balance (in shares) at Jun. 30, 2021   52,080      
Beginning balance at Jun. 30, 2021 157,392 $ 130 602,877 1,423 (447,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive income (loss) (2,103)     (243) (1,860)
Issuance of common stock upon exercise of stock options (in shares)   131      
Issuance of common stock upon exercise of stock options 812   812    
Issuance of common stock for vested restricted stock units (in shares)   578      
Issuance of common stock for vested restricted stock units 0 $ 2 (2)    
Tax withholding related to vesting of restricted stock units (in shares)   (130)      
Tax withholding related to vesting of restricted stock units (1,269)   (1,269)    
Stock-based compensation costs 2,309   2,309    
Ending Balance (in shares) at Sep. 30, 2021   52,659      
Ending balance at Sep. 30, 2021 $ 157,141 $ 132 $ 604,727 $ 1,180 $ (448,898)